68 related articles for article (PubMed ID: 8258335)
1. Half-life of antigen/major histocompatibility complex class II complexes in vivo: intra- and interorgan variations.
Müller KP; Schumacher J; Kyewski BA
Eur J Immunol; 1993 Dec; 23(12):3203-7. PubMed ID: 8258335
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells.
Farr A; DeRoos PC; Eastman S; Rudensky AY
Eur J Immunol; 1996 Dec; 26(12):3185-93. PubMed ID: 8977321
[TBL] [Abstract][Full Text] [Related]
3. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules.
Calin-Laurens V; Forquet F; Mottez E; Kanellopoulos J; Godeau F; Kourilsky P; Gerlier D; Rabourdin-Combe C
Eur J Immunol; 1991 Mar; 21(3):761-9. PubMed ID: 2009914
[TBL] [Abstract][Full Text] [Related]
5. Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells.
Colledge L; Bennett CL; Reay PA; Blackburn CC
Eur J Immunol; 2002 Nov; 32(11):3246-55. PubMed ID: 12555670
[TBL] [Abstract][Full Text] [Related]
6. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
[TBL] [Abstract][Full Text] [Related]
7. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.
Lazarski CA; Chaves FA; Jenks SA; Wu S; Richards KA; Weaver JM; Sant AJ
Immunity; 2005 Jul; 23(1):29-40. PubMed ID: 16039577
[TBL] [Abstract][Full Text] [Related]
8. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
Agrawal B; Manickasundari M; Fraga E; Singh B
J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
[TBL] [Abstract][Full Text] [Related]
9. Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules.
Adams S; Albericio F; Alsina J; Smith ER; Humphreys RE
Arzneimittelforschung; 1997 Sep; 47(9):1069-77. PubMed ID: 9342425
[TBL] [Abstract][Full Text] [Related]
10. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing.
Moss CX; Villadangos JA; Watts C
Eur J Immunol; 2005 Dec; 35(12):3442-51. PubMed ID: 16259009
[TBL] [Abstract][Full Text] [Related]
11. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
12. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
Dang LH; Lien LL; Benacerraf B; Rock KL
J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
[TBL] [Abstract][Full Text] [Related]
13. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody specific for a cytochrome c T cell stimulatory peptide inhibits T cell responses and affects the way the peptide associates with antigen-presenting cells.
Jemmerson R; Johnson JG; Burrell E; Taylor PS; Jenkins MK
Eur J Immunol; 1991 Jan; 21(1):143-51. PubMed ID: 1846813
[TBL] [Abstract][Full Text] [Related]
15. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo.
Grant EP; Rock KL
J Immunol; 1992 Jan; 148(1):13-8. PubMed ID: 1727862
[TBL] [Abstract][Full Text] [Related]
16. Patterns of major histocompatibility complex class II expression by T cell subsets in different immunological compartments. 2. Altered expression and cell function following activation in vivo.
Hopkins J; McConnell I; Dalziel RG; Dutia BM
Eur J Immunol; 1993 Nov; 23(11):2889-96. PubMed ID: 8223865
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex regulation of T helper functions mapped to a peptide C terminus that controls ligand density.
Murray JS; Ferrandis-Edwards D; Wolfe CJ; Schountz T
Eur J Immunol; 1994 Oct; 24(10):2337-44. PubMed ID: 7925562
[TBL] [Abstract][Full Text] [Related]
18. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell.
Nelson CA; Petzold SJ; Unanue ER
Nature; 1994 Sep; 371(6494):250-2. PubMed ID: 8078585
[TBL] [Abstract][Full Text] [Related]
19. Antigen-presenting cells in the thymus that can negatively select MHC class II-restricted T cells recognizing a circulating self antigen.
Volkmann A; Zal T; Stockinger B
J Immunol; 1997 Jan; 158(2):693-706. PubMed ID: 8992985
[TBL] [Abstract][Full Text] [Related]
20. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]